Filing Flows › Centene (CNC) › Q3 2026 › vs Q3 2025
Centene (CNC) Q3 2026 vs Q3 2025 (year over year)
Centene's revenue rose $957M (+2%) from $49.7B in Q3 2025 to $50.6B in Q3 2026. The biggest changes: Commercial −$2.3B (-21%); Medicare +$1.9B (+20%); Medicaid +$1.6B (+6%).
Centene, Q3 2026: revenue $50.6B (+2% year over year), operating margin -0.6%, net loss $65.0M, operating cash flow −$3.7B. The chart draws each line against Q3 2025, the increases inside each band.
Every line
| Line | Q3 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| Medicaid | $29.6B | $28.0B | $1.6B | +6% |
| Medicare | $11.3B | $9.4B | $1.9B | +20% |
| Commercial | $8.7B | $11.0B | −$2.3B | -21% |
| Other | $1.1B | $1.3B | −$241M | -18% |
| Revenue | $50.6B | $49.7B | $957M | +2% |
| Other income, net | $185M | $280M | −$95.0M | -34% |
| Income tax benefit | $57.0M | $42.0M | $15.0M | +36% |
| Net loss | $65.0M | $6.6B | −$6.6B | -99% |
| Costs & expenses | $51.0B | $56.6B | −$5.7B | -10% |
| Operating costs | $51.0B | $56.6B | −$5.7B | -10% |
| Cost of revenue | $47.3B | $46.3B | $1.0B | +2% |
| SG&A | $3.2B | $3.1B | $90.0M | +3% |
| Other operating costs | $374M | $7.2B | −$6.8B | -95% |
| Operating cash sources | $4.0B | −$987M | $5.0B | — |
| Depreciation & amortization | $299M | $317M | −$18.0M | -6% |
| Share-based compensation | $52.0M | $52.0M | $0 | 0% |
| Cash used in operations | $3.7B | −$1.4B | $5.0B | — |
| Net loss absorbed | $65.0M | $6.6B | −$6.6B | -99% |
| Working capital & other | $4.0B | −$7.6B | $11.6B | — |
Questions
How much did Centene's revenue grow year over year in Q3 2026?
Centene's revenue rose $957M (+2%) from $49.7B in Q3 2025 to $50.6B in Q3 2026.
What drove Centene's revenue change in Q3 2026?
Commercial −$2.3B (-21%); Medicare +$1.9B (+20%); Medicaid +$1.6B (+6%).